Investors in Venture

TNN CAPITAL: Financial services company providing investment opportunities, wealth management, and financial advisory solutions for individuals and businesses.At TNN Capital, we proactively work with clients and families to accumulate, preserve and successfully transfer wealth across generations. In today’s ever changing environment, our mission is to provide independent and objective advice, by understanding and simplifying the complexities affluent families are faced with when it comes to wealth management. But we also ensure that our expertise is executed with the utmost discretion and commitment to excellence.

Tech Family Ventures invests in early-stage companies and supports them in shaping their growth strategies with fundraising, business development and technology solutions by seasoned entrepreneurs and public funding experts, while leveraging a global network in 65+ countries.

Save Company 2be.lu was established in Luxembourg in 2014, to help early stage companies execute their global ambitions. Today our venture capital portfolio consists of a dozen companies that improve the lives of many around the world. We support our portfolio companies with our experience and network of contacts on a range of legal, financial and operational issues. In 2017 we added a focus on crypto currencies and established a separate Crypto Fund.

Dedicated is a venture capital investment boutique that sources and structures a variety of high potential deals for private investors. From extremely ambitious bets with the highest risk/return ratios, through more conservative but still exciting investments, up to exclusive allocations in highly demanded rounds (e.g. Airbnb, SpaceX, OpenAI), all of them shaping the future. Humble, we thrive for excellence through ambition and hard work.

Société Familiale d'Investissements S.A. ("SFI") is an affiliate of Patrinvest SCA.Patrinvest SCA holds the interests of some of the founding families of Anheuser-Busch InBev, the leading global brewer and one of the world's top consumer products companies. Our investment philosophy is focused on the very long term.

Careventures is an independent pan-European private equity firm that invests in high-growth and profitable small and mid-cap companies in the healthcare services sector. Founded in 2014 by four senior partners bringing together substantial investment, operational and entrepreneurial experience in sizeable and successful multinational healthcare ventures, with over 100 investments executed within healthcare services over two decades. Careventures builds and grows successful business platforms in unconsolidated niches within European healthcare services by executing multiple follow-on acquisitions, accurately addressing and exploiting technological shifts and/or changes in regulatory environments.

Candy Ventures is a portfolio of global companies funded by British entrepreneur Nick Candy. We back visionary founders with global ambitions and leverage our exceptional network to powerfully accelerate businesses and ideas.To date we have funded over 25 companies across several sectors, including fintech, deep tech and augmented reality, digital media, consumer and sports, biotech, water infrastructure and natural resources.

NP Capital, headquartered in Luxembourg, is a Venture Capital firm that specializes in investments in growth and late-stage private technology companies in the US, Europe, and emerging markets.

Black Swan Equity Partners LLP is an investment advisor based in London, specializing in providing strategic advice and investment solutions. The firm focuses on advising clients on investment strategies and opportunities across various sectors. With a commitment to delivering tailored financial solutions, Black Swan Equity Partners works closely with investors and businesses to optimize their investment portfolios and achieve their financial goals. The firm's expertise lies in offering personalized advisory services that cater to the unique needs and objectives of its clients, aiming to build long-term value and sustainable growth.

Humanity will always depend on medicines. Continuous innovation in the biotech sector is a given. Bringing better medicines to the market all the time. The Aescap Life Sciences and Aescap Genetics funds invest in highly innovative publicly traded biotech/life sciences companies. These companies are developing tomorrow’s medicines. Investing in Aescap funds offers the possibility to achieve excellent returns over the medium term, without taking large risks. Both funds have a focused portfolio, based on deep fundamental analyses and a strict buy and sell discipline. The Aescap funds act under the Article 8 of the EU Sustainable Finance Disclosure Regulation (SFDR) and operate under a AIFM license.

Foresight Group, we are a leading independent investor headquartered in the United Kingdom, specializing in infrastructure, private equity, and environmental sectors. Our focus on sustainability drives our investment strategy as we manage funds for institutional and private investors globally, aiming to deliver attractive, risk-adjusted returns. With expertise spanning renewable energy, waste management, sustainable infrastructure, and technology-driven growth businesses, we actively seek opportunities to support companies in scaling and realizing their full potential. Integrating environmental, social, and governance (ESG) considerations into our investment decisions, we strive to create positive impacts and sustainable outcomes across our diverse portfolio. With a strong track record and a commitment to innovation, we continue to drive economic growth while contributing to environmental sustainability and societal well-being worldwide.

Founded in 1984 by Queen's University Belfast, QUBIS Ltd is dedicated to commercializing the university's research and development activities through the creation of spin-out businesses. We play a crucial role in this process by acquiring equity in new spin-out ventures, leveraging investments in cash and/or Intellectual Property. Our primary mission is to transition innovative R&D from the laboratory to the commercial marketplace. At QUBIS Ltd, we proactively identify and evaluate commercially viable research and resources within Queen's University. We collaborate closely with skilled management teams and partners who possess the necessary market expertise to drive these ventures forward. Our approach is market-driven, focusing exclusively on ventures with strong market validation and demand. We recognize the importance of partnering with private or trade investors who can contribute not only capital but also valuable market access. This collaboration allows us to effectively navigate market challenges and leverage established distribution systems or market presence. By bridging academia and industry, we are committed to facilitating the transformation of cutting-edge research into impactful innovations that benefit society and drive economic growth.